|
Biogen
In November 2003, Biogen Idec Inc. (NASDAQ: BIIB)
was formed from the merger of two of the world’s leading biotechnology
companies, Biogen, Inc. and IDEC Pharmaceuticals Corporation. This combination
has resulted in a fusion of complementary strengths in therapeutic focus,
research and development capabilities, manufacturing expertise, global
infrastructure and financial position. Biogen Idec intends to continue its
growth through discovery, development and commercialization of its own
innovative products and through strategic alliances as the preferred partner
for biologics development, manufacturing and marketing.
Biogen Idec is dedicated to pursuing the
creativity of science. The company’s products and development programs address
a variety of key medical needs in the areas of oncology, neurology,
dermatology and rheumatology.
Careers in Biotechnology
We invite you
to explore our Careers in Biotechnology Section and get a feel for who we are
— not just our story, but the people behind the story, who are truly the heart
and soul of Biogen Idec.Search our
current listings of jobs available across North America and Europe and submit
your resume to a global leader in pharmaceutical biotechnology today!
For more details |
|
Last Updated ( Saturday, 05 March 2005 )
|
